Proteonomix, Inc.
PROT
Rank in Stocks
#35156
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics... Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The companyโs products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$791.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Proteonomix, Inc. (PROT)
Category
Healthcare
EPS for Proteonomix, Inc. (PROT)
EPS as of June 2012 TTM: $-0.22
According to Proteonomix, Inc.'s latest financial reports, its current EPS (TTM) is $-0.22. At the end of 2011 the company had an EPS of $-0.21, an increase over its 2010 EPS of $-0.75.
EPS history for Proteonomix, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.22 | 4.76% |
| 2011 | $-0.21 | -72.00% |
| 2010 | $-0.75 | -35.34% |
| 2009 | $-1.16 | -50.21% |
| 2008 | $-2.33 | -102.25% |
| 2002 | $103.70 | -300.00% |
| 2001 | $-51.85 | -83.33% |
| 2000 | $-311.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -7,218.18% |
US
|
|
| $-7.07 | 3,113.64% |
US
|
|
| $-5.29 | 2,304.55% |
AU
|
|
| $12.88 | -5,954.59% |
BE
|
|
| $21.56 | -9,900.00% |
NL
|
Questions about Proteonomix, Inc.'s earnings per share (EPS)
What is Proteonomix, Inc.'s earnings per share (EPS)?
Proteonomix, Inc.'s earnings per share (EPS) over the last twelve months is $-0.22, as of Jun 2012.
What was Proteonomix, Inc.'s earnings per share (EPS) in 2011?
In 2011, Proteonomix, Inc.'s earnings per share (EPS) was $-0.21, compared with $-0.75 in 2010.
How has Proteonomix, Inc.'s earnings per share (EPS) changed since 2008?
From 2008 to 2011, Proteonomix, Inc.'s earnings per share (EPS) was highest in 2011 ($-0.21) and lowest in 2008 ($-2.33).
How does Proteonomix, Inc.'s earnings per share (EPS) compare with similar companies?
Proteonomix, Inc.'s earnings per share (EPS) ($-0.22) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.